India, Oct. 27 -- Merck & Co., Inc. (MRK) announced positive results from the Phase 3 KEYNOTE-C93 trial, evaluating KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, as monotherapy for the treatmen... Read More
India, Oct. 27 -- Japan Exchange Group, Inc. (OSK.F) released a profit for its first half that Increased, from the same period last year The company's bottom line came in at JPY57.210 billion, or JPY... Read More
India, Oct. 27 -- Indian shares were moving lower in early trade on Tuesday as investors awaited earnings from major U.S. technology companies and the Federal Reserve's interest-rate decision for dire... Read More
India, Oct. 26 -- Xencor, Inc. (XNCR) is up 23.87 percent, gaining $6.01 to $31.19 on Monday. The surge appears to follow positive clinical data announced Sunday for XmAb819, the company's investigati... Read More
India, Oct. 26 -- On Monday, Scienjoy Holding Corporation (SJ) reported higher income in the first half of 2026, compared to the same half last year. Net income attributable to the shareholders rose ... Read More
India, Oct. 26 -- TransCode Therapeutics, Inc. (RNAZ) presented Phase 1a clinical data for TTX-MC138, an investigational RNA-based therapy targeting metastatic cancers, at the European Society for Med... Read More
India, Oct. 26 -- Oruka Therapeutics, Inc. (ORKA) is up 11.69 percent, gaining $9.37 to $89.52 on Monday. The rise follows positive Week 16 results from the company's EVERLAST-B Phase 2b trial evaluat... Read More
India, Oct. 26 -- Can-Fite BioPharma Ltd. (CANF), a clinical-stage biotechnology company developing small molecule therapeutics, announced the final data from its Phase 2a clinical study of namodenoso... Read More
India, Oct. 26 -- Monday, Anthropic (ANT) announced its plan to list its Class A common stock on the Nasdaq Global Select Market under the symbol 'ANT.' As part of the plan, the AI giant has filed a ... Read More
India, Oct. 26 -- Biohaven Ltd. (BHVN) presented preclinical data for BHV-1420, an investigational drug designed to selectively remove the autoantibodies that drive membranous nephropathy, at the Amer... Read More